LifeBond enrolling patients in LifeSeal surgical sealant study: 4 key notes

Caesarea, Israel-based LifeBond is enrolling patients in the United States and Western Europe for its LifeSeal Surgical Sealant’s IDE clinical trial.

Advertisement

Here’s what you should know.

1. LifeBond partnered with 20 medical centers to enroll patients into the study.

2. LifeBond will announce an additional 20 clinical sites soon.

3. Several Western European countries commercially use LifeSeal, which earned a CE Mark in April 2016.

4. The gastrointestinal-facing sealant provides reinforcement and minimize staple-line leakage.

More articles on gastroenterology:
GI leader to know: Dr. Ismail Wadiwala of Sutter Health
RedHill Biopharma’s Bekinda phase III study treats last patient: 4 things to know
Cantel Medical to acquire distributor’s endoscopy business assets: 3 key notes

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in GI & Endoscopy

  • Birmingham (Ala.) Gastroenterology has opened a clinic in Jasper, Ala., expanding access to digestive health services in the region, the…

  • Premier Health Partners has acquired Dayton, Ohio-based Digestive Specialists, according to a notice posted on the website of law firm…

Advertisement

Comments are closed.